drugset / Trial / NCT05004441
Fruquintinib Combined With mFOLFOX6/FOLFIRI in First-line Treatment for Metastatic Colorectal Cancer
Phase 2
Unknown
43 enrolled
Zhou Fuxiang
Henan Cancer Hospital · collabHuangshi Central Hospital · collabHubei Cancer Hospital · collabXiangya Hospital of Central South University · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Fruquintinib Combined With mFOLFOX6/FOLFIRI as the first-line treatment of Metastatic Colorectal Cancer
Timeline
- Start
- 2021-07-22
- Primary completion
- 2022-12-30
- Completion
- 2023-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fruquintinib | Small molecule | 3 mg | Oral |